Genetic Technologies Limited (GTG) Company Profile

Genetic Technologies Limited Company Snapshot

Genetic Technologies Limited operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Genetic Technologies Limited with three other pharmaceutical manufacturers in Australasia: Alterity Therapeutics Ltd (2018 sales of 201,174.00 Australian Dollars [US$144,418.79 ] ), Auscann Group Holdings Ltd (235,064.00 Australian Dollars [US$168,747.74 ] ), and Prescient Therapeutics Ltd (125,156.00 Australian Dollars [US$89,846.99 ] ).

Sales Analysis. Genetic Technologies Limited reported sales of A$189,254.00 (US$135.86 thousand) for the fiscal year ending June of 2018. This represents a sharp decrease of 63.5% versus 2017, when the company's sales were A$518,506.00 .

Genetic Technologies Limited

Stock Data:

Recent Stock Performance:

Current Price (4/18/2019): .01
(Figures in Australian Dollars)

1 Week	0.0%	13 Weeks	-6.7%

4 Weeks	-17.6%	52 Weeks	-41.7%

Genetic Technologies Limited Key Data:

Ticker:	GTG	Country:	Australia

Exchanges:	OTC	Major Industry:	Pharmaceuticals & Biotechnology

		Sub Industry:	Biological Products Exc. Diagnostic

2018 Sales	189,254 (Year Ending Jan 2019).	Employees:	56

Currency:	Australian Dollars	Market Cap:	17,046,979

Fiscal Yr Ends:	June	Shares Outstanding:	2,435,282,724

Share Type:	Ordinary	Closely Held Shares:	216,334,869

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.